Search

everythinglearnresearchcommunity

for

Search:↓

Topical squaric acid dibutylester worsened discoid lupus erythematosus in a patient.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Anti-Desmocollin 3 antibodies can cause pemphigus-like symptoms in mice.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Combining hair transplantation with PRP is more effective for treating hair loss than hair transplantation alone.

Early genetic testing and JAK inhibitors can help treat systemic inflammation in SAVI patients.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

Etanercept effectively treated a severe skin condition when other treatments failed.

3D spheroid culture makes stem cells better at reducing inflammation.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Nearly half of children with primary immunodeficiency disorders showed skin problems, often as the first sign of their condition.

Combining systemic steroids and dithranol can effectively regrow hair in severe alopecia areata.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

Ustekinumab significantly improved psoriasis, vitiligo, and alopecia areata in a patient.

New mouse models of Pemphigus show severe symptoms and need better treatments.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Sex hormones influence immune responses and may help treat diseases.

Bullous pemphigoid, intrahepatic cholangiocarcinoma, and alopecia areata may share immune-related causes.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.